These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2265247)

  • 21. Functional Roles of the von Willebrand Factor Propeptide.
    Rawley O; Lillicrap D
    Hamostaseologie; 2021 Feb; 41(1):63-68. PubMed ID: 33588457
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Composition of the von Willebrand factor storage organelle (Weibel-Palade body) isolated from cultured human umbilical vein endothelial cells.
    Ewenstein BM; Warhol MJ; Handin RI; Pober JS
    J Cell Biol; 1987 May; 104(5):1423-33. PubMed ID: 3494734
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A new von Willebrand variant (type I, New York): increased ristocetin-induced platelet aggregation and plasma von Willebrand factor containing the full range of multimers.
    Weiss HJ; Sussman II
    Blood; 1986 Jul; 68(1):149-56. PubMed ID: 3487353
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Von Willebrand factor: molecular size and functional activity.
    Furlan M
    Ann Hematol; 1996 Jun; 72(6):341-8. PubMed ID: 8767102
    [TBL] [Abstract][Full Text] [Related]  

  • 25. von Willebrand factor remodeling during exocytosis from vascular endothelial cells.
    Mourik MJ; Valentijn JA; Voorberg J; Koster AJ; Valentijn KM; Eikenboom J
    J Thromb Haemost; 2013 Nov; 11(11):2009-19. PubMed ID: 24010820
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ion.
    Tsai HM
    Blood; 1996 May; 87(10):4235-44. PubMed ID: 8639782
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biosynthesis of sulfated asparagine-linked complex carbohydrate units of calf thyroglobulin.
    Spiro MJ; Spiro RG
    Endocrinology; 1988 Jul; 123(1):56-65. PubMed ID: 3383787
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantitative analysis of von Willebrand factor propeptide release in vivo: effect of experimental endotoxemia and administration of 1-deamino-8-D-arginine vasopressin in humans.
    Borchiellini A; Fijnvandraat K; ten Cate JW; Pajkrt D; van Deventer SJ; Pasterkamp G; Meijer-Huizinga F; Zwart-Huinink L; Voorberg J; van Mourik JA
    Blood; 1996 Oct; 88(8):2951-8. PubMed ID: 8874191
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carbohydrate moiety of von Willebrand factor is not necessary for maintaining multimeric structure and ristocetin cofactor activity but protects from proteolytic degradation.
    Federici AB; Elder JH; De Marco L; Ruggeri ZM; Zimmerman TS
    J Clin Invest; 1984 Dec; 74(6):2049-55. PubMed ID: 6239876
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Triplet structure of human von Willebrand factor.
    Fischer BE; Thomas KB; Schlokat U; Dorner F
    Biochem J; 1998 Apr; 331 ( Pt 2)(Pt 2):483-8. PubMed ID: 9531488
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Limited proteolysis of human von Willebrand factor by Staphylococcus aureus V-8 protease: isolation and partial characterization of a platelet-binding domain.
    Girma JP; Chopek MW; Titani K; Davie EW
    Biochemistry; 1986 Jun; 25(11):3156-63. PubMed ID: 3015200
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel mutation in the D3 domain of von Willebrand factor markedly decreases its ability to bind factor VIII and affects its multimerization.
    Jorieux S; Gaucher C; Goudemand J; Mazurier C
    Blood; 1998 Dec; 92(12):4663-70. PubMed ID: 9845532
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential intracellular trafficking of von Willebrand factor (vWF) and vWF propeptide in porcine endothelial cells lacking Weibel-Palade bodies and in human endothelial cells.
    Royo T; Martínez-González J; Vilahur G; Badimon L
    Atherosclerosis; 2003 Mar; 167(1):55-63. PubMed ID: 12618268
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Divergent fates of von Willebrand factor and its propolypeptide (von Willebrand antigen II) after secretion from endothelial cells.
    Wagner DD; Fay PJ; Sporn LA; Sinha S; Lawrence SO; Marder VJ
    Proc Natl Acad Sci U S A; 1987 Apr; 84(7):1955-9. PubMed ID: 3494248
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduction of von Willebrand factor by endothelial cells.
    Xie L; Chesterman CN; Hogg PJ
    Thromb Haemost; 2000 Sep; 84(3):506-13. PubMed ID: 11019979
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.
    Gadisseur A; Berneman Z; Schroyens W; Michiels JJ
    Acta Haematol; 2009; 121(2-3):128-38. PubMed ID: 19506359
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of carbohydrate modifications of factor VIII/von Willebrand factor on binding to platelets.
    Goudemand J; Mazurier C; Samor B; Bouquelet S; Montreuil J; Goudemand M
    Thromb Haemost; 1985 Jun; 53(3):390-5. PubMed ID: 2864750
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heterogeneity of plasma von Willebrand factor multimers resulting from proteolysis of the constituent subunit.
    Dent JA; Galbusera M; Ruggeri ZM
    J Clin Invest; 1991 Sep; 88(3):774-82. PubMed ID: 1909351
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of abnormal von Willebrand factor by endothelial cells from a patient with type IIA von Willebrand disease.
    Levene RB; Booyse FM; Chediak J; Zimmerman TS; Livingston DM; Lynch DC
    Proc Natl Acad Sci U S A; 1987 Sep; 84(18):6550-4. PubMed ID: 3306682
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gamma-interferon modulates von Willebrand factor release by cultured human endothelial cells.
    Tannenbaum SH; Gralnick HR
    Blood; 1990 Jun; 75(11):2177-84. PubMed ID: 2112031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.